Topics:

Osteoporosis

Osteoporosis

Look no further: The North American Menopause Society has issued recommendations that offer the latest information for managing a woman's health through menopause.

A quiz in JAMA uses a case with discordant DXA results to discuss the options in assessment of hip fracture risk in osteoporosis, describing their advantages and drawbacks.

Bisphosphonates offer women no protection against breast cancer but do help prevent fractures related to osteoporosis.

Eliglustat has a better safety profile than the existing approved oral drug for type 1 Gaucher disease, and is easier to take than enzyme replacement therapy.

Whatever is causing this woman's hip pain, her x-ray looks quite severe. The diagnosis was correct 40 years ago, but it couldn't be treated effectively then. What's the problem?

For the success of total hip replacements, 35 is the magic number, a very large Canadian study finds. Procedures done by surgeons with lower volumes per year have much greater failure risks.

Among women with osteoporosis randomized to discontinue bisphosphonates, results of bone mass testing in subsequent years were unrelated to future fracture risk. This undercuts guidelines and even a law.

Pages

Subscribe to Osteoporosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.